GlobeNewswire Inc.··NaCartesian Therapeutics to Present CAR-T Pipeline at BioConnect Conference
Late-stage biotech Cartesian Therapeutics presenting at H.C. Wainwright conference May 19, advancing Descartes-08 CAR-T therapy across multiple autoimmune indications.
RNACclinical developmentautoimmune diseases